Glypican-3 Antibody from MYBIOSOURCE INC.

Search, find, compare suppliers for anti-Glypican-3 antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityGlypican-3
Clone[IHC405]
Host SpeciesMouse
Reactive Specieshuman
Isotypen/a
Formatunconjugated
Size0.1 mL (Concentrate), 7 mL (Prediluted), 1 mL (Concentrate)
Concentrationn/a
Applicationsn/a
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionGlypican-3 (GPC3) is a GPI-archored proteoglycan involved in cell division and growth regulation. Glypican-3 is a useful tumor marker, and its expression has been shown to be upregulated in hepatocellular carcinoma (HCC), hepatoblastoma, melanoma, testicular germ cell tumors, and Wilms' tumor. Patients with HCC have presented elevated levels of GPC3 in the neoplastic liver tissues and serum, which is higher than cirrhotic liver or liver with focal lesions including those with hepatic adenoma and dysplastic nodules. Glypican-3 is also overexpressed in testicular germ cell tumors of certain subtypes, such as yolk sac tumors and choriocarcinoma, and in embryonal tumors.
Immunogenn/a
Other Names[Glypican-3, partial; Glypican-3; Glypican-3], [GPC3]
Gene, Accession #NCBI: ETE59825.1
Catalog #MBS344030
Price$245, $435, $735
Order / More InfoGlypican-3 Antibody from MYBIOSOURCE INC.
Product Specific References1. Capurro M, et al. Gastroenterology. 2003; 125:89-97.2. Coston WMP, et al. Am J Surg Pathol. 2008; 32:433-44.3. Kandil D, et al. Cancer. 2007; 111:316-22.4. Zynger DL, et al. Hum Pathol. 2008; 39:224-30.5. Kandil DH, et al. Adv Anat Pathol. 2009; 16:125-9.6. Zynger DL, et al. Am J Surg Pathol. 2006; 30:1570-5.
MYBIOSOURCE INC.
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166

sales@mybiosource.com

http://www.MyBioSource.com

Profile of MYBIOSOURCE INC.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.